Atlas Trials

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Clinical trial NCT00752856 · COMPLETED

Trial details

NCT number
NCT00752856
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2008-08-26
Primary completion
2011-05-05
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.